Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.
Endomag has raised €17M across 1 funding round from 1 investor, most recently a Series D+ round in Nov 2020. Based in Cambridge, UK; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-30 | Series D+ | €17M |
| Draper Esprit |
| View deal → |
